has been cited by the following article(s):
[1]
|
The Role of Oxidative Stress in Acute Ischemic Stroke-Related Thrombosis
Oxidative Medicine and Cellular Longevity,
2022
DOI:10.1155/2022/8418820
|
|
|
[2]
|
Is edaravone harmful? (A placebo is not a control)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,
2018
DOI:10.1080/21678421.2018.1517179
|
|
|
[3]
|
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy)
Stroke,
2017
DOI:10.1161/STROKEAHA.116.015042
|
|
|
[4]
|
Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis
Oxidative Medicine and Cellular Longevity,
2017
DOI:10.1155/2017/6873281
|
|
|
[5]
|
Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets
Experimental Eye Research,
2016
DOI:10.1016/j.exer.2016.03.020
|
|
|
[6]
|
The free-radical scavenger edaravone accelerates thrombolysis with alteplase in an experimental thrombosis model
Thrombosis Research,
2015
DOI:10.1016/j.thromres.2015.04.011
|
|
|